echemi logo
Product
  • Product
  • Supplier
  • Inquiry

    up to date!

    • Last Update: 2021-11-11
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Hydroxychloroquine (HCQ) and chloroquine (CQ) are drugs used to treat systemic lupus erythematosus and rheumatoid arthritis


    Hydroxychloroquine (HCQ) and chloroquine (CQ) are drugs used to treat systemic lupus erythematosus and rheumatoid arthritis


    On October 26, the American College of Rheumatology (ACR) released a white paper summarizing the current understanding of hydroxychloroquine (HCQ)/chloroquine (CQ) cardiotoxicity, and proposed risk assessment and monitoring guidance based on consensus


    Due to reports that HCQ and CQ have potential anti-coronavirus activity in the new crown epidemic, the use of this drug has increased in early 2020


    Cardiotoxicity of HCQ/CQ

    Cardiotoxicity of HCQ/CQ Cardiotoxicity of HCQ/CQ

    HCQ and CQ interact with ventricular myocytes by blocking potassium efflux channels, leading to prolonged QT c


    HCQ and CQ interact with ventricular myocytes by blocking potassium efflux channels, leading to prolonged QT c


    C: The repolarization of normal cardiomyocytes is caused by potassium ions flowing out of the cell through the HERG channel


    D: HCQ or CQ will cause the outflow of potassium ions to be blocked

     

     

    The QT interval (referred to as QT) includes the activation time of ventricular depolarization and repolarization.


    The QT interval (referred to as QT) includes the activation time of ventricular depolarization and repolarization.


    High-risk groups High-risk groups

     

    In addition to drugs, there are other factors that can prolong QT.


    In addition to drugs, there are other factors that can prolong QT.



    Drugs that can lead to prolonged QTc of patients Drugs that can lead to prolonged QTc of patients

    If the patient has symptoms of arrhythmia, such as syncope, presyncope, or unexplained dizziness, a cardiac evaluation including an electrocardiogram should be performed in accordance with FDA label recommendations


    If the patient has symptoms of arrhythmia, such as syncope, presyncope, or unexplained dizziness, a cardiac evaluation including an electrocardiogram should be performed in accordance with FDA label recommendations


     

    The incidence of severe arrhythmia caused by hydroxychloroquine in patients with rheumatism is unclear


    The incidence of severe arrhythmia caused by hydroxychloroquine in patients with rheumatism is unclear


    Antimalarial therapy can reduce the amount of glucocorticoids, reduce the risk of cardiovascular disease, reduce organ damage and control the disease in the treatment of SLE disease
    .
    As a doctor, you should weigh the toxicity of drugs to the heart.
    Although the benefits of drugs far outweigh the risks, you should also be aware of drug toxicity
    .
    Original: Desmarais J, Rosenbaum JT, Costenbader KH, et al.
    American College of Rheumatology White Paper on Antimalarial CardiacToxicity[J].
    Arthritis Rheumatol.
    2021 Oct 26.
    doi: 10.
    1002/art.
    41934.
    Epubahead of print.


    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.